Home LiteratureArticle Details
PMID: 19727860 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Neurofibromatosis 1 and dental caries.

Clinical oral investigations ·Vol. 15 ·No. 1 ·2011-02-00 ·页码 119-21

Visnapuu V, Pienihäkkinen K, Peltonen S, Happonen RP, Peltonen J

Abstract

A total of 110 patients with neurofibromatosis 1 (NF1) were evaluated for their dental health. Appropriate cohorts from national Finnish databases were used as reference. The results showed that NF1 patients presented lower rate of caries compared to controls in age groups under 35 years. The differences between NF1 patients and the reference population diminished by age. In conclusion, (1) NF1 per se does not predispose to caries; and (2) even if NF1 had an adverse effect on dental health, poor outcome can be counteracted with good personal dental care supported by well organized primary health care. The results of the present study are important to report since a common anecdotal perception is that the rate of caries may be higher in NF1 compared to reference population.

MeSH 主题词
Adolescent Adult Age Factors Aged Child Child, Preschool DMF Index Dental Caries/complications Female Finland Humans Male Middle Aged Neurofibromatosis 1/complications Oral Health Young Adult
作者与单位
共 5 位作者,点击展开单位 / ORCID
Visnapuu Vivian
Department of Cell Biology and Anatomy, University of Turku, Kiinamyllynkatu 10, 20520 Turku, Finland. vivvis@utu.fi
Pienihäkkinen Kaisu
Peltonen Sirkku
Happonen Risto-Pekka
Peltonen Juha
Article Info
Journal
Clinical oral investigations
Abbr.
Clin Oral Investig
ISSN
1436-3771
Corresponding email
Published
2011-02-00
电子出版
2009-00-02
页码
119-21
Language
English
Country/Region
Germany
NLM ID
9707115
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com